May 02, 2024 / 08:30PM GMT
Operator
Good day and welcome to the Q1 2024 Ascendis Pharma Earnings Conference Call. (Operator Instructions) As a reminder, this call may be recorded. I would now like to turn the call over to Tim Lee, Senior Director, Investor Relations of Ascendis Pharma. Please go ahead.
Tim Lee - Ascendis Pharma A/S-Senior Director of IR
Thank you, operator, and thank you, everyone, for joining our first quarter 2024 financial results conference call on Tim Lee, Senior Director, Investor Relations at Ascendis Pharma. Joining me on the call today are Jan Mikkelsen, President and Chief Executive Officer; Scott Smith, Executive Vice President and Chief Financial Officer; Dr. Stina Singel, Executive Vice President of Clinical Development Oncology; and Joe Kelley, US General Manager.
Before we begin, I'd like to remind you that this conference call will contain forward-looking statements that are intended to be covered under the Safe Harbor provided by the Private Securities Litigation Reform Act. Examples of such statement may include but are
Q1 2024 Ascendis Pharma A/S Earnings Call Transcript
May 03, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers